Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Molecular Markers of Artemisinin Resistance in Plasmodium Falciparum Malaria: Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda

NCT04037332 is registered in ClinicalTrials.gov with Swiss Tropical & Public Health Institute as lead sponsor.

NCT NCT04037332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04037332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Molecular Markers of Artemisinin Resistance in Plasmodium Falciparum Malaria: Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda
Lead sponsor
Swiss Tropical & Public Health Institute
Phase
Observational
Overall status
Completed
Start date
July 27, 2018
Completion date
July 31, 2020
Enrollment
916 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

severe malaria